structured Lab Digitization
Move from paper-based records and spreadsheets to controlled digital workflows across sample registration, testing, documentation, review, and approval. Improve consistency, traceability, and operational control.
A paperless pharmaceutical QC lab is built by connecting the core systems and workflows that manage samples, experiments, instrument data, approvals, and compliance. For many laboratories, this shift begins with reducing dependence on paper records, spreadsheets, and disconnected software, then moving toward a structured digital environment powered by LIMS, ELN, and SDMS. This content hub brings together the key topics that matter when planning a pharma QC lab digitization strategy
Centralize all laboratory operations into a single environment that connects experiments, results, instrument data, and approvals. By bringing everything together, teams can monitor progress in real time, reduce redundant effort, and simplify oversight. This approach enhances operational clarity, accelerates decision-making, and ensures every activity is transparent and easy to track.
Moving toward a digital QC lab starts with understanding how information flows today, from sample receipt and registration to testing, experiment documentation, raw data capture, review, and final approval. This article outlines a practical path for labs that want to reduce manual handling and build a more connected, traceable, and compliant quality control environment.
A LIMS for pharmaceutical QC labs is one of the most important building blocks of a paperless laboratory. This article explains why QC environments need LIMS and what features matter most when selecting a system for regulated testing operations. For readers comparing solutions, this is a practical guide to choosing a LIMS that supports both daily operations and long-term digital transformation.
For laboratories still relying on handwritten documentation, the move from paper notebooks to Electronic Lab Notebooks is a major step toward a paperless pharmaceutical laboratory. This article compares traditional paper-based documentation with ELN-based workflows in a pharmaceutical context. It shows how ELNs improve structure, accessibility, collaboration, and traceability while also fitting into a broader digital lab ecosystem alongside LIMS and SDMS.
The decision to go paperless is not only operational. It is also financial. This article looks at what influences the cost of a paperless QC lab and how organizations can think about digitization as an investment across systems, workflows, integration needs, and long-term efficiency gains.
Learn the benefits of implementing a LIMS in your laboratory for quality control testing
A LIMS proposal becomes stronger when it is framed in financial and operational terms, not just technical ones. This article helps laboratory and quality teams present LIMS software as an investment in workflow efficiency, visibility, control, and scalability.
Choosing a LIMS also means choosing how it will be deployed. This article compares cloud vs on-premise LIMS for pharma by looking at infrastructure responsibility, cost structure, scalability, performance, security, data control, and compliance considerations. Rather than treating one model as universally better, it helps pharmaceutical organizations evaluate which deployment approach fits their IT capacity, operational priorities, and long-term strategy.
CFR Gateway is a compliance layer developed by Agaram Technologies that enforces 21 CFR Part 11 and EudraLex Annex 11 compliance on any laboratory instrument or software application including legacy and non-compliant systems without requiring you to replace or modify your existing setup. It loads at system startup and acts as a controlled gateway through which users must authenticate before accessing any application. Every user action, data modification, and file access is automatically tracked and stored in a secure, tamper-proof server repository, making your lab audit-ready at all times. Download CFR Gateway Brochure
Yes. CFR Gateway is specifically designed to bring non-compliant and legacy lab instruments into full 21 CFR Part 11 compliance without replacing the instrument or its software. It wraps around any existing PC-based instrument software and enforces role-based access control, immutable audit trails with date and time stamps, electronic signatures, and secure server storage — all of which are mandated under 21 CFR Part 11. This means even instruments running older, non-compliant software can operate within a fully regulated, audit-ready environment. Contact Sales for A Personalized Demo
Yes. CFR Gateway is fully aligned with both FDA 21 CFR Part 11 (US) and EudraLex Annex 11 (EU/UK) requirements for electronic records and electronic signatures in regulated pharmaceutical environments. This makes it suitable for pharmaceutical, biotech, and life sciences labs operating across multiple geographies, including those subject to MHRA oversight in the UK. The system enforces the same core data integrity controls — audit trails, access control, version control, and secure data storage — that both regulatory frameworks mandate.